MC1101A1 - Composition a activite retardee - Google Patents

Composition a activite retardee

Info

Publication number
MC1101A1
MC1101A1 MC761182A MC1182A MC1101A1 MC 1101 A1 MC1101 A1 MC 1101A1 MC 761182 A MC761182 A MC 761182A MC 1182 A MC1182 A MC 1182A MC 1101 A1 MC1101 A1 MC 1101A1
Authority
MC
Monaco
Prior art keywords
delayed
release
formulation
weight
benzodiazepine
Prior art date
Application number
MC761182A
Other languages
English (en)
French (fr)
Inventor
J Tossounian
P Sheth
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of MC1101A1 publication Critical patent/MC1101A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC761182A 1975-03-17 1976-03-15 Composition a activite retardee MC1101A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
MC1101A1 true MC1101A1 (fr) 1977-02-04

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
MC761182A MC1101A1 (fr) 1975-03-17 1976-03-15 Composition a activite retardee

Country Status (21)

Country Link
JP (1) JPS51115910A (enExample)
AR (1) AR222624A1 (enExample)
AT (1) AT353415B (enExample)
AU (1) AU505355B2 (enExample)
CA (1) CA1073358A (enExample)
CH (1) CH630257A5 (enExample)
DD (1) DD124102A5 (enExample)
DE (1) DE2611041A1 (enExample)
DK (1) DK148344C (enExample)
ES (1) ES446075A1 (enExample)
FR (1) FR2304354A1 (enExample)
GB (1) GB1546448A (enExample)
GR (1) GR60341B (enExample)
IE (1) IE43083B1 (enExample)
LU (1) LU74558A1 (enExample)
MC (1) MC1101A1 (enExample)
NL (1) NL190313C (enExample)
NZ (1) NZ180321A (enExample)
PH (1) PH14927A (enExample)
PT (1) PT64907B (enExample)
SE (1) SE433804B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CA2107678A1 (en) * 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
AU692483B2 (en) * 1993-10-29 1998-06-11 R.P. Scherer Corporation Gelatin capsule fill able to foam
CA2190188A1 (en) * 1994-05-13 1995-11-23 Prasad S. Adusumilli Method and composition for increasing calcium uptake
MX9704043A (es) * 1994-12-01 1998-02-28 Cibus Pharmaceuticals Inc Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine
WO2026022379A1 (en) * 2024-07-26 2026-01-29 Inkvivo Technologies Sa Gastroretentive formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (enExample) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
IE43083L (en) 1976-09-17
PT64907A (fr) 1976-04-01
AU505355B2 (en) 1979-11-15
SE433804B (sv) 1984-06-18
JPS638084B2 (enExample) 1988-02-19
NZ180321A (en) 1978-06-20
DK148344C (da) 1985-11-04
AR222624A1 (es) 1981-06-15
ES446075A1 (es) 1977-09-16
DK113676A (da) 1976-09-18
NL7602776A (nl) 1976-09-21
CA1073358A (en) 1980-03-11
DK148344B (da) 1985-06-17
PT64907B (fr) 1978-03-24
GR60341B (en) 1978-05-17
DD124102A5 (enExample) 1977-02-02
PH14927A (en) 1982-01-29
AT353415B (de) 1979-11-12
IE43083B1 (en) 1980-12-17
DE2611041C2 (enExample) 1988-06-09
ATA192276A (de) 1979-04-15
SE7603325L (sv) 1976-09-18
NL190313C (nl) 1994-01-17
JPS51115910A (en) 1976-10-13
FR2304354B1 (enExample) 1979-04-27
GB1546448A (en) 1979-05-23
AU1204976A (en) 1977-09-22
DE2611041A1 (de) 1976-10-14
CH630257A5 (en) 1982-06-15
NL190313B (nl) 1993-08-16
LU74558A1 (enExample) 1977-09-27
FR2304354A1 (fr) 1976-10-15

Similar Documents

Publication Publication Date Title
TWI241188B (en) Sertraline salts and sustained-release dosage forms of sertraline
BE1000616A5 (fr) Formulation pharmaceutique.
US4167558A (en) Novel sustained release tablet formulations
JP2509226B2 (ja) ニトロフラントイン投薬型
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
CA2415378C (fr) Composition pharmaceutique orale a liberation controlee et a absorption prolongee
US4140755A (en) Sustained release tablet formulations
BE904899A (fr) Compositions therapeutiques flottantes a degagement progressif.
FR2488508A1 (fr) Capsule analgesique alcaline
FR2568472A1 (fr) Preparations pharmaceutiques retard et procede pour les fabriquer
DK148344B (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof
FR2518409A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose
FR2523845A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose de poids moleculaire eleve
NL8203343A (nl) Farmaceutisch preparaat.
EA000804B1 (ru) Твердая лекарственная форма, содержащая производные цизаприда, способ ее получения, продукт, содержащий твердую лекарственную форму, фармацевтическая упаковка
WO2007106960A1 (en) Controlled-release floating dosage forms
JPS62501845A (ja) 制御放出塩化カリウム
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
EP1615632B1 (fr) Formulations orales flottantes pour la liberation controlee de la betaine
FR2967576A1 (fr) Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
EP1646379A2 (fr) Nouvelle composition pharmaceutique solide comprenant de l a misulpride
WO2004032942A1 (fr) Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
EP0983065A1 (fr) Composition pharmaceutique a residence gastrique
CN112822998B (zh) 新型剂型
BE839604A (fr) Composition a activite retardee

Legal Events

Date Code Title Description
YP Annual fee paid